Our Research
The long-term goal of Marike Gabrielson’s research group is to reduce recurrence and mortality in breast cancer by therapeutic prevention and personalised adjuvant therapy. This is done by focusing on two essential areas: identifying who will most benefit from preventive therapeutic measures, and by tailoring adjuvantcare of patients with breast cancer.
Ongoing projects in the group include among others:
- The POWER trial; a randomised clinical trial to test individualised adjuvant therapy with tamoxifen for patients with breast cancer
- Understanding the mechanisms of action of endocrine cancer therapy in preventing breast cancer, and identifying biomarkers for tailoring individualised preventive and adjuvant therapy
- Identifying predictors of therapy discontinuation and therapeutic effect
- Deciphering the molecular epidemiology of breast cancer risk, and identifying biomarkers of risk within the breast tissue and by hormone and proteomic profiles
- Better understanding of the biology of mammographic breast density as a risk factor for breast cancer
Join Us
We are always seeking passionate and dedicated researchers to join our group. If you are interested in contributing to groundbreaking research in breast cancer aetiology and prevention, we invite you to connect with us and explore opportunities within our group.